-
公开(公告)号:US20070032487A1
公开(公告)日:2007-02-08
申请号:US10554559
申请日:2004-04-30
申请人: Ian Bruce , Bernard Cuenoud , Thomas Keller , Gaynor Pilgrim , Nicola Press , Darren Le Grand , Cathy Ritchie , Barbara Valade , Judy Hayler , Emma Budd
发明人: Ian Bruce , Bernard Cuenoud , Thomas Keller , Gaynor Pilgrim , Nicola Press , Darren Le Grand , Cathy Ritchie , Barbara Valade , Judy Hayler , Emma Budd
IPC分类号: A61K31/5377 , A61K31/506 , A61K31/497 , A61K31/4439 , C07D417/14 , C07D417/04
CPC分类号: A61K31/5377 , A61K31/497 , A61K45/06 , C07D417/04 , C07D417/14
摘要: Compounds of formula I in free or salt form, wherein R1, R2, R3 and R4 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
摘要翻译: 游离或盐形式的式I化合物,其中R 1,R 2,R 3和R 4, 具有说明书中所示的含义,可用于治疗由磷脂酰肌醇3-激酶介导的病症。 还描述了含有化合物的药物组合物和制备该化合物的方法。
-
公开(公告)号:US20110105535A1
公开(公告)日:2011-05-05
申请号:US13005132
申请日:2011-01-12
申请人: Ian BRUCE , Bernard Cuenoud , Thomas Hugo Keller , Gaynor Elizabeth Pilgrim , Nicola Press , Darren Mark Le Grand , Cathy Ritchie , Barbara Valade , Judy Hayler , Emma Budd
发明人: Ian BRUCE , Bernard Cuenoud , Thomas Hugo Keller , Gaynor Elizabeth Pilgrim , Nicola Press , Darren Mark Le Grand , Cathy Ritchie , Barbara Valade , Judy Hayler , Emma Budd
IPC分类号: A61K31/506 , C07D417/14 , A61P3/04 , C07D471/04 , A61P11/00 , A61P37/08 , A61P35/00 , A61P1/00 , A61P3/10
CPC分类号: A61K31/5377 , A61K31/497 , A61K45/06 , C07D417/04 , C07D417/14
摘要: Compounds of formula I in free or salt form, wherein R1, R2, R3 and R4 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by phosphatidylinositol 3-kinase.Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
摘要翻译: 游离或盐形式的式I化合物,其中R 1,R 2,R 3和R 4具有说明书中所示的含义,可用于治疗由磷脂酰肌醇3-激酶介导的病症。 还描述了含有化合物的药物组合物和制备该化合物的方法。
-
公开(公告)号:US08404684B2
公开(公告)日:2013-03-26
申请号:US13005132
申请日:2011-01-12
申请人: Ian Bruce , Bernard Cuenoud , Thomas Hugo Keller , Gaynor Elizabeth Pilgrim , Nicola Press , Darren Mark Le Grand , Cathy Ritchie , Barbara Valade , Judy Hayler , Emma Budd
发明人: Ian Bruce , Bernard Cuenoud , Thomas Hugo Keller , Gaynor Elizabeth Pilgrim , Nicola Press , Darren Mark Le Grand , Cathy Ritchie , Barbara Valade , Judy Hayler , Emma Budd
IPC分类号: C07D417/04 , A61K31/506
CPC分类号: A61K31/5377 , A61K31/497 , A61K45/06 , C07D417/04 , C07D417/14
摘要: Compounds of formula I in free or salt form, wherein R1, R2, R3 and R4 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
摘要翻译: 游离或盐形式的式I化合物,其中R 1,R 2,R 3和R 4具有说明书中所示的含义,可用于治疗由磷脂酰肌醇3-激酶介导的病症。 还描述了含有化合物的药物组合物和制备该化合物的方法。
-
公开(公告)号:US20080319033A1
公开(公告)日:2008-12-25
申请号:US12097723
申请日:2006-12-13
IPC分类号: C07D277/48 , C07D417/12 , A61K31/426 , A61K31/427 , A61P11/00 , A61P37/08
CPC分类号: C07D277/48 , C07D417/12
摘要: Compounds of formula I in free or salt form, wherein R1, R2, R3, R4 and X have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
摘要翻译: 游离或盐形式的式I化合物,其中R 1,R 2,R 3,R 4和X具有说明书中所示的含义,可用于治疗由磷脂酰肌醇3-激酶介导的疾病。 还描述了含有化合物的药物组合物和用于制备化合物的方法。
-
公开(公告)号:US07754746B2
公开(公告)日:2010-07-13
申请号:US12097723
申请日:2006-12-13
IPC分类号: C07D413/12 , C07D411/12 , C07D277/48 , A61K31/427 , A61K31/426
CPC分类号: C07D277/48 , C07D417/12
摘要: Compounds of formula I in free or salt form, wherein R1, R2, R3, R4 and X have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
摘要翻译: 游离或盐形式的式I化合物,其中R1,R2,R3,R4和X具有说明书中所示的含义,可用于治疗由磷脂酰肌醇3-激酶介导的疾病。 还描述了含有化合物的药物组合物和用于制备化合物的方法。
-
-
-
-